I was diagnosed with Stage 4 prostate cancer in summer 2023...PSA peaked at about 10. Using Firmagon and Zytiga, PSA dropped to 0.03 in December 2023. My MO declared I was 'castration sensitive' around that time. Over the next 15 months, my PSA increased to 1.21 (while still on Firmagon, Zytiga for a bit before switching to Xtandi because of liver enzyme issues) After starting docetaxel infusions last month, my PSA is back down to 0.18...hopefully to drop further.
Clinically, should I now be categorized as 'castration sensitive' or 'castration resistant? The reason I ask is that some potential treatments (Erleada, Nubeqa) will depend on how my condition is classified.
Any help is much appreciated. My doctor's only comments was that I seemed to be 'on my way' to castration resistance, but that was before by PSA dropped to less than 0.20.